CN116492443A - 一种足浴液及其制备方法 - Google Patents
一种足浴液及其制备方法 Download PDFInfo
- Publication number
- CN116492443A CN116492443A CN202310571016.7A CN202310571016A CN116492443A CN 116492443 A CN116492443 A CN 116492443A CN 202310571016 A CN202310571016 A CN 202310571016A CN 116492443 A CN116492443 A CN 116492443A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- foot bath
- bath liquid
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000006210 lotion Substances 0.000 title claims description 5
- 239000000284 extract Substances 0.000 claims abstract description 132
- 239000007788 liquid Substances 0.000 claims abstract description 69
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 239000000419 plant extract Substances 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 8
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 8
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 8
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 8
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 8
- 229940116229 borneol Drugs 0.000 claims abstract description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940002508 ginger extract Drugs 0.000 claims abstract description 8
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 8
- 229940064064 purslane extract Drugs 0.000 claims abstract description 8
- 235000005412 red sage Nutrition 0.000 claims abstract description 8
- 239000003381 stabilizer Substances 0.000 claims abstract description 8
- 239000004094 surface-active agent Substances 0.000 claims abstract description 8
- 239000000725 suspension Substances 0.000 claims abstract description 8
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 3
- 229940069445 licorice extract Drugs 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims description 28
- 238000002791 soaking Methods 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000004806 packaging method and process Methods 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 241000212322 Levisticum officinale Species 0.000 claims description 5
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 5
- 244000030166 artemisia Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 5
- 239000001645 levisticum officinale Substances 0.000 claims description 5
- 235000011477 liquorice Nutrition 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 3
- 239000003814 drug Substances 0.000 description 29
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 206010062519 Poor quality sleep Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种足浴液,包括足浴液组合物、植物提取物以及水,所述的足浴液组合物包括以下重量份原料:表面活性剂5‑10份、悬浮稳定剂0.5‑1份、pH调节剂0.1‑2份;所述的植物提取物包括以下重量份原料:红景天提取物15‑30份、马齿苋提取物20‑40份、菟丝子提取物20‑40份、丹参提取物12‑25份、当归提取物15‑30份、川芎提取物15‑30份、艾叶提取物30‑50份、姜提取物20‑40份、冰片提取物5‑12份、甘草提取物5‑12份、白花蛇舌草提取物5‑12份、秦皮提取物3‑10份。本发明中的植物经深加工提取有效成分制成足浴液,灭菌清洁脚部,使用方便,特别适合风热感冒人群使用,原料易得,制备方法简单、成本低。
Description
技术领域
本发明涉及中药组合物技术领域,具体是指一种足浴液及其制备方法。
背景技术
随着社会的发展和生活节奏的加快,来自于社会、工作、生活等方面的压力越来越大,人们对加强身体保健的需要日益迫切,人体免疫力低下不能抵抗外来因素的抗衡时,生理功能就会失去平衡从而产生疾病,尤其是肝肾、风湿、阴虚、免疫力低下造成的各种疾病。中药浴足疗法是根据传统中医理论,采用中药外用浴足,通过皮肤黏膜吸收和药液的温热熏洗使药物离子迅速进入到血液中,使药性通过穴位直达脏腑,刺激全身穴位,疏通经气,调理气血,中医理论认为通过刺激这些穴位,可达到疏通经气,调理气血,调节脏腑功能的作用。
人的双足具有运行气血、联络脏腑、沟通内外、贯穿上下的功能,每个人双脚上有60余个穴位,均与全身器官有相应关系。足浴可以促进人体脚部血液循环,达到改善脚部经络,促进人体健康的目的。足浴保健在今天更是蔚然成风,得到了更大的发展。随着药物副作用的增多和药源性疾病的不断涌现,越来越多的人们更加崇尚自然保健法。足部区域是一个能反映全身信息的全息胚。由于足部血管神经分布密集,足三阴、三阳经在脚部相互贯通,通过经络***与全身连通,所以说,脚部是人体信息相对集中的地方。各种生理病理的信息均可在足部显现出来。临床运用时,针对不同的病情,选择一定的反射区进行组合,可以调整相应脏腑经络气血的功能,从而达到治疗疾病的目的。
其中,足部浸泡属于中医药外治法,它是在中医理论的指导下选择适当的中草药,利用药物浸液产生的蒸汽熏蒸以达到防治疾病的目的。药液直接作用于人体皮肤或患处,具有疏通经络和调理气血,刺激神经和心血管***,改善局部营养状况和调节全身各器官功能的作用,是中医治疗中一种古老而有效的治疗方法。其利用热水促进药物渗透进人体的作用,即可保证药物能通过脚部透达周身经络,又不会出现口服药物过量导致不良反应的情况。
作为绿色疗法的足浴疗法,由于其操作简单,方便舒适,效果显著,得到了大家的认可。中药足浴中药物的摄取和内服药物相比具有安全、舒适、方便、无毒副作用等优点。如何找到一种行之有效的足浴液配方是关键。
发明内容
本发明要解决上述技术问题,提供一种足浴液及其制备方法。
为解决上述技术问题,本发明提供的技术方案为:一种足浴液,包括足浴液组合物、植物提取物以及水,所述的足浴液组合物包括以下重量份原料:表面活性剂5-10份、悬浮稳定剂0.5-1份、pH调节剂0.1-2份;所述的植物提取物包括以下重量份原料:红景天提取物15-30份、马齿苋提取物20-40份、菟丝子提取物20-40份、丹参提取物12-25份、当归提取物15-30份、川芎提取物15-30份、艾叶提取物30-50份、姜提取物20-40份、冰片提取物5-12份、甘草提取物5-12份、白花蛇舌草提取物5-12份、秦皮提取物3-10份。
作为本发明选择的一种技术方案,所述的足浴液组合物、植物提取物的重量份比例为(50-70):(30-50)。
作为本发明选择的一种技术方案,所述的足浴液组合物包括以下重量份原料:表面活性剂8份、悬浮稳定剂0.8份、pH调节剂1.5份。
作为本发明选择的一种技术方案,所述的植物提取物包括以下重量份原料:红景天提取物20份、马齿苋提取物30份、菟丝子提取物30份、丹参提取物20份、当归提取物20份、川芎提取物20份、艾叶提取物40份、姜提取物30份、冰片提取物10份、甘草提取物10份、白花蛇舌草提取物10份、秦皮提取物5份。
作为本发明选择的一种技术方案,所述的足浴液组合物还包括防腐剂0.1-0.2份。
根据权利要求1所述的一种足浴液的制备方法,包括以下步骤:
S1、预处理:分别称取植物提取物的原料,粉碎后过50-100目筛,然后分别加水浸泡;
S2、制备植物提取物:将原料与浸泡液的混合物分别依次进行水提处理、混合处理、浓缩处理以及灭菌处理,得到红景天提取物、马齿苋提取物、菟丝子提取物、丹参提取物、当归提取物、川芎提取物、艾叶提取物、姜提取物、冰片提取物、甘草提取物、白花蛇舌草提取物、秦皮提取物;
S3、混合包装:将所述的植物提取物与所述的足浴液组合物混合均匀,分装即可得到本发明的足浴液。
作为本发明选择的一种技术方案,在S3混合包装时按重量加入0.1-0.2%防腐剂。
作为本发明选择的一种技术方案,在S2制备植物提取物时,所述的水提处理的温度为60℃-80℃,料液比为1:(4-7),提取次数为3-5次。
作为本发明选择的一种技术方案,在S2制备植物提取物时,所述的混合处理为超声混合处理,将原料与浸泡液的混合物置于超声波提取机中进行超声萃取1~2小时,设置的压力为常压,温度为60~80℃,超声频率为250~400HZ。
作为本发明选择的一种技术方案,在S2制备植物提取物时,所述的浓缩处理为:超声萃取后,取超声混合处理后的上层清液,然后过滤,得滤液,滤液浓缩至0.1~1g/mL。
本发明具有如下优点:
1、本发明的中药组合物所选药材配伍相宜,符合中医药学和现代医药学理论,足浴液通过温煦体表穴位,透达经络达到暖气血温经脉逐寒湿的作用;可健脾渗湿,治疗脾胃虚弱、倦怠乏力、食少便溏,又可益心脾而宁心安神,治疗心脾两虚、气血不足之心悸、失眠、健忘;补养阴血,养心安神,对于阴虚血少之失眠多梦,心神不宁,头目眩晕等症有明显改善效果;
2、本发明通过温和药物,利用皮肤的御邪、分泌、吸收、渗透、***、感觉等多种功能,作用于局部皮肤、肌肉、关节,改善三者的代谢、强化其功能,并且通过皮肤对药物的吸收,通过经络将药力送达机体内部而发挥不同的作用,并透过肌表祛邪外出,达到缓解疲劳、改善睡眠、疏通经脉、调理脏腑等保健作用。可有效改善睡眠不良、代谢紊乱、疲劳倦怠症状,适用长期精神紧张、睡眠质量差、熬夜工作者及老年人群。
3、本发明中的植物经深加工提取有效成分制成足浴液,灭菌清洁脚部,使用方便,特别适合风热感冒人群使用,原料易得,制备方法简单、成本低。
上述概述仅仅是为了说明书的目的,并不意图以任何方式进行限制。除上述描述的示意性的方面、实施方式和特征之外,通过参考附图和以下的详细描述,本发明进一步的方面、实施方式和特征将会是容易明白的。
附图说明
为了更清楚地说明本申请实施例或现有技术中的技术方案,下面将对实施例或有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本申请的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1是本发明一种足浴液的制备方法的流程图。
具体实施方式
下面结合全文对本发明做进一步的详细说明。
结合附图1,实施例一:一种足浴液,包括足浴液组合物、植物提取物以及水,所述的足浴液组合物包括以下重量份原料:表面活性剂8份、悬浮稳定剂0.8份、pH调节剂1.5份;所述的足浴液组合物还包括防腐剂0.1份。
所述的植物提取物包括以下重量份原料:红景天提取物20份、马齿苋提取物30份、菟丝子提取物30份、丹参提取物20份、当归提取物20份、川芎提取物20份、艾叶提取物40份、姜提取物30份、冰片提取物10份、甘草提取物10份、白花蛇舌草提取物10份、秦皮提取物5份。
所述的足浴液组合物、植物提取物的重量份比例为50:50。
根据权利要求1所述的一种足浴液的制备方法,包括以下步骤:
S1、预处理:分别称取植物提取物的原料,粉碎后过70目筛,然后分别加水浸泡;
S2、制备植物提取物:将原料与浸泡液的混合物分别依次进行水提处理、混合处理、浓缩处理以及灭菌处理,得到红景天提取物、马齿苋提取物、菟丝子提取物、丹参提取物、当归提取物、川芎提取物、艾叶提取物、姜提取物、冰片提取物、甘草提取物、白花蛇舌草提取物、秦皮提取物;
其中,所述的水提处理的温度为70℃,料液比为1:5,提取次数为5次;所述的混合处理为超声混合处理,将原料与浸泡液的混合物置于超声波提取机中进行超声萃取2小时,设置的压力为常压,温度为70℃,超声频率为300HZ;所述的浓缩处理为:超声萃取后,取超声混合处理后的上层清液,然后过滤,得滤液,滤液浓缩至0.5g/mL。
S3、混合包装:将所述的植物提取物与所述的足浴液组合物混合均匀,分装即可得到本发明的足浴液。在S3混合包装时按重量加入0.2防腐剂。
实施例二:所述的足浴液组合物包括以下重量份原料:表面活性剂5份、悬浮稳定剂0.5份、pH调节剂0.1份;所述的植物提取物包括以下重量份原料:红景天提取物15份、马齿苋提取物20份、菟丝子提取物20份、丹参提取物12份、当归提取物15份、川芎提取物15份、艾叶提取物30份、姜提取物20份、冰片提取物5份、甘草提取物5份、白花蛇舌草提取物5份、秦皮提取物3份。
所述的足浴液组合物、植物提取物的重量份比例为(50-70):(30-50)。
根据权利要求1所述的一种足浴液的制备方法,包括以下步骤:
S1、预处理:分别称取植物提取物的原料,粉碎后过50目筛,然后分别加水浸泡;
S2、制备植物提取物:将原料与浸泡液的混合物分别依次进行水提处理、混合处理、浓缩处理以及灭菌处理,得到红景天提取物、马齿苋提取物、菟丝子提取物、丹参提取物、当归提取物、川芎提取物、艾叶提取物、姜提取物、冰片提取物、甘草提取物、白花蛇舌草提取物、秦皮提取物;
其中,所述的水提处理的温度为60℃,料液比为1:4,提取次数为3次;所述的混合处理为超声混合处理,将原料与浸泡液的混合物置于超声波提取机中进行超声萃取1小时,设置的压力为常压,温度为60℃,超声频率为250HZ;所述的浓缩处理为:超声萃取后,取超声混合处理后的上层清液,然后过滤,得滤液,滤液浓缩至0.1g/mL。
S3、混合包装:将所述的植物提取物与所述的足浴液组合物混合均匀,分装即可得到本发明的足浴液。在S3混合包装时按重量加入0.1%防腐剂。
实施例三:一种足浴液,包括足浴液组合物、植物提取物以及水,所述的足浴液组合物包括以下重量份原料:表面活性剂10份、悬浮稳定剂1份、pH调节剂2份;所述的植物提取物包括以下重量份原料:红景天提取物30份、马齿苋提取物40份、菟丝子提取物40份、丹参提取物25份、当归提取物30份、川芎提取物30份、艾叶提取物50份、姜提取物40份、冰片提取物12份、甘草提取物12份、白花蛇舌草提取物12份、秦皮提取物10份。
所述的足浴液组合物、植物提取物的重量份比例为60:40。
根据权利要求1所述的一种足浴液的制备方法,包括以下步骤:
S1、预处理:分别称取植物提取物的原料,粉碎后过100目筛,然后分别加水浸泡;
S2、制备植物提取物:将原料与浸泡液的混合物分别依次进行水提处理、混合处理、浓缩处理以及灭菌处理,得到红景天提取物、马齿苋提取物、菟丝子提取物、丹参提取物、当归提取物、川芎提取物、艾叶提取物、姜提取物、冰片提取物、甘草提取物、白花蛇舌草提取物、秦皮提取物;
其中,所述的水提处理的温度为80℃,料液比为1:7,提取次数为5次;所述的混合处理为超声混合处理,将原料与浸泡液的混合物置于超声波提取机中进行超声萃取2小时,设置的压力为常压,温度为80℃,超声频率为400HZ;所述的浓缩处理为:超声萃取后,取超声混合处理后的上层清液,然后过滤,得滤液,滤液浓缩至1g/mL。
S3、混合包装:将所述的植物提取物与所述的足浴液组合物混合均匀,分装即可得到本发明的足浴液。在S3混合包装时按重量加入0.2%防腐剂。
本发明的中药组合物所选药材配伍相宜,符合中医药学和现代医药学理论,足浴液通过温煦体表穴位,透达经络达到暖气血温经脉逐寒湿的作用;可健脾渗湿,治疗脾胃虚弱、倦怠乏力、食少便溏,又可益心脾而宁心安神,治疗心脾两虚、气血不足之心悸、失眠、健忘;补养阴血,养心安神,对于阴虚血少之失眠多梦,心神不宁,头目眩晕等症有明显改善效果;本发明通过温和药物,利用皮肤的御邪、分泌、吸收、渗透、***、感觉等多种功能,作用于局部皮肤、肌肉、关节,改善三者的代谢、强化其功能,并且通过皮肤对药物的吸收,通过经络将药力送达机体内部而发挥不同的作用,并透过肌表祛邪外出,达到缓解疲劳、改善睡眠、疏通经脉、调理脏腑等保健作用。可有效改善睡眠不良、代谢紊乱、疲劳倦怠症状,适用长期精神紧张、睡眠质量差、熬夜工作者及老年人群。本发明中的植物经深加工提取有效成分制成足浴液,灭菌清洁脚部,使用方便,特别适合风热感冒人群使用,原料易得,制备方法简单、成本低。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,全文中所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (10)
1.一种足浴液,其特征在于,包括足浴液组合物、植物提取物以及水,所述的足浴液组合物包括以下重量份原料:表面活性剂5-10份、悬浮稳定剂0.5-1份、pH调节剂0.1-2份;所述的植物提取物包括以下重量份原料:红景天提取物15-30份、马齿苋提取物20-40份、菟丝子提取物20-40份、丹参提取物12-25份、当归提取物15-30份、川芎提取物15-30份、艾叶提取物30-50份、姜提取物20-40份、冰片提取物5-12份、甘草提取物5-12份、白花蛇舌草提取物5-12份、秦皮提取物3-10份。
2.根据权利要求1所述的一种足浴液,其特征在于,所述的足浴液组合物、植物提取物的重量份比例为(50-70):(30-50)。
3.根据权利要求1所述的一种足浴液,其特征在于,所述的足浴液组合物包括以下重量份原料:表面活性剂8份、悬浮稳定剂0.8份、pH调节剂1.5份。
4.根据权利要求3所述的一种足浴液及其制备方法,其特征在于,所述的植物提取物包括以下重量份原料:红景天提取物20份、马齿苋提取物30份、菟丝子提取物30份、丹参提取物20份、当归提取物20份、川芎提取物20份、艾叶提取物40份、姜提取物30份、冰片提取物10份、甘草提取物10份、白花蛇舌草提取物10份、秦皮提取物5份。
5.根据权利要求1所述的一种足浴液及其制备方法,其特征在于,所述的足浴液组合物还包括防腐剂0.1-0.2份。
6.根据权利要求1所述的一种足浴液的制备方法,其特征在于,包括以下步骤:
S1、预处理:分别称取植物提取物的原料,粉碎后过50-100目筛,然后分别加水浸泡;
S2、制备植物提取物:将原料与浸泡液的混合物分别依次进行水提处理、混合处理、浓缩处理以及灭菌处理,得到红景天提取物、马齿苋提取物、菟丝子提取物、丹参提取物、当归提取物、川芎提取物、艾叶提取物、姜提取物、冰片提取物、甘草提取物、白花蛇舌草提取物、秦皮提取物;
S3、混合包装:将所述的植物提取物与所述的足浴液组合物混合均匀,分装即可得到本发明的足浴液。
7.根据权利要求6所述的一种足浴液及其制备方法,其特征在于,在S3混合包装时按重量加入0.1-0.2%防腐剂。
8.根据权利要求6所述的一种足浴液及其制备方法,其特征在于,在S2制备植物提取物时,所述的水提处理的温度为60℃-80℃,料液比为1:(4-7),提取次数为3-5次。
9.根据权利要求8所述的一种足浴液及其制备方法,其特征在于,在S2制备植物提取物时,所述的混合处理为超声混合处理,将原料与浸泡液的混合物置于超声波提取机中进行超声萃取1~2小时,设置的压力为常压,温度为60~80℃,超声频率为250~400HZ。
10.根据权利要求9所述的一种足浴液及其制备方法,其特征在于,在S2制备植物提取物时,所述的浓缩处理为:超声萃取后,取超声混合处理后的上层清液,然后过滤,得滤液,滤液浓缩至0.1~1g/mL。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310571016.7A CN116492443A (zh) | 2023-05-20 | 2023-05-20 | 一种足浴液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310571016.7A CN116492443A (zh) | 2023-05-20 | 2023-05-20 | 一种足浴液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116492443A true CN116492443A (zh) | 2023-07-28 |
Family
ID=87318252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310571016.7A Withdrawn CN116492443A (zh) | 2023-05-20 | 2023-05-20 | 一种足浴液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116492443A (zh) |
-
2023
- 2023-05-20 CN CN202310571016.7A patent/CN116492443A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111388641A (zh) | 一种多功能养生健康足浴包、足浴药液及其应用 | |
CN103028090B (zh) | 一种治疗气虚的中药组合物 | |
CN110693977A (zh) | 一种治疗早泄和***功能障碍的外用中药及其制备方法 | |
CN112656930A (zh) | 一种生发、乌发的中药洗发水及其制备方法 | |
CN107469044A (zh) | 一种具有暖脾活络驱寒作用的泡脚中药组合物及其制备方法 | |
CN1045888C (zh) | 一种健身足浴药物 | |
CN102908425B (zh) | 一种治疗心脏病及血脂稠的药物及其制备方法 | |
CN105456379A (zh) | 一种治疗血虚肠燥便秘药汤及其制备方法 | |
CN104606561A (zh) | 一种治疗自汗的中药组合物 | |
CN108524594A (zh) | 健脾草药茶组合物、健脾草药茶制剂及其制备方法 | |
CN116492443A (zh) | 一种足浴液及其制备方法 | |
CN103463588A (zh) | 一种治疗中气下陷的中药组合物 | |
CN102895166A (zh) | 含防治高血压药物组份的沐足露 | |
CN112353874A (zh) | 一种阳虚体质复方油 | |
CN1087619C (zh) | 抗骨松片 | |
CN104083580A (zh) | 一种治疗老年痴呆病中药 | |
CN109010559A (zh) | 一种用于制备温补壮阳配制酒的中药组合物及配制酒 | |
CN103356962B (zh) | 一种治疗更年期综合症的中药组合物 | |
CN108187020A (zh) | 一种中药制剂的制备方法及其在治疗眩晕症中的应用 | |
CN105853508A (zh) | 一种用于治疗手足寒凉麻木的中药组合物及其制备方法 | |
CN105267862A (zh) | 一种治疗室性早搏中药 | |
CN104758539A (zh) | 一种治疗乏力的中药组合物 | |
CN112546188A (zh) | 一种能量膏、能量膏的制备方法及设备 | |
CN104784588A (zh) | 一种用于治疗神经性头痛的中药制剂及制备方法 | |
CN104189744A (zh) | 一种用于治疗老年人肝气郁滞性遗尿病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230728 |
|
WW01 | Invention patent application withdrawn after publication |